SecSonar.com

Canopy Growth Corporation (CGC)

Canopy Growth Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Canopy Growth Corporation (CGC) is a Drug Manufacturers - Specialty & Generic company based in CA with a market capitalization of $468.3M. Revenue declined 9.5% year-over-year and free cash flow was negative at -$124.7M. This page tracks CGC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 1.03K employees · IPO Apr 7, 2014

Valuation

Valuation & price

$1.04 · as of May 26, 2026 · -45.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.67

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.83$1.36$0.89Jul 25Dec 25Jul 26Jul 7, 25$1.20Jul 9, 25$1.26Jul 11, 25$1.13Jul 15, 25$1.09Jul 17, 25$1.11Jul 21, 25$1.12Jul 23, 25$1.17Jul 25, 25$1.14Jul 29, 25$1.02Jul 31, 25$1.03Aug 4, 25$1.10Aug 6, 25$1.05Aug 11, 25$1.58Aug 13, 25$1.64Aug 15, 25$1.30Aug 19, 25$1.25Aug 21, 25$1.24Aug 25, 25$1.44Aug 27, 25$1.51Aug 29, 25$1.80Sep 3, 25$1.40Sep 5, 25$1.46Sep 9, 25$1.45Sep 11, 25$1.39Sep 16, 25$1.45Sep 18, 25$1.38Sep 22, 25$1.32Sep 24, 25$1.42Sep 26, 25$1.34Sep 30, 25$1.46Oct 2, 25$1.36Oct 6, 25$1.39Oct 8, 25$1.53Oct 10, 25$1.37Oct 14, 25$1.36Oct 16, 25$1.35Oct 21, 25$1.37Oct 23, 25$1.32Oct 27, 25$1.32Oct 29, 25$1.25Oct 31, 25$1.24Nov 4, 25$1.13Nov 6, 25$1.09Nov 10, 25$1.27Nov 12, 25$1.19Nov 14, 25$1.07Nov 18, 25$1.07Nov 20, 25$1.01Nov 25, 25$1.19Nov 28, 25$1.17Dec 2, 25$1.11Dec 4, 25$1.21Dec 8, 25$1.09Dec 10, 25$1.15Dec 12, 25$1.74Dec 16, 25$1.83Dec 18, 25$1.69Dec 22, 25$1.32Dec 24, 25$1.31Dec 29, 25$1.21Jan 2, 26$1.19Jan 6, 26$1.18Jan 8, 26$1.29Jan 12, 26$1.23Jan 14, 26$1.22Jan 16, 26$1.19Jan 21, 26$1.14Jan 23, 26$1.19Jan 27, 26$1.17Jan 29, 26$1.11Feb 2, 26$1.09Feb 4, 26$1.16Feb 9, 26$1.09Feb 11, 26$1.07Feb 13, 26$1.08Feb 18, 26$1.15Feb 20, 26$1.19Feb 24, 26$1.17Feb 26, 26$1.14Mar 2, 26$1.07Mar 4, 26$1.08Mar 6, 26$1.07Mar 10, 26$1.06Mar 12, 26$1.04Mar 17, 26$1.07Mar 19, 26$1.01Mar 23, 26$0.97Mar 25, 26$0.97Mar 27, 26$0.89Mar 31, 26$0.95Apr 2, 26$1.00Apr 7, 26$0.99Apr 9, 26$1.09Apr 13, 26$1.08Apr 15, 26$1.15Apr 17, 26$1.14Apr 22, 26$1.38Apr 24, 26$1.19Apr 28, 26$1.15Apr 30, 26$1.11May 4, 26$1.10May 6, 26$1.15May 8, 26$1.11May 12, 26$1.09May 14, 26$1.07May 18, 26$0.98May 20, 26$1.03May 22, 26$1.04May 28, 26$1.12Jun 1, 26$1.08Jun 3, 26$1.04Jun 5, 26$1.03Jun 9, 26$1.02Jun 11, 26$1.01Jun 15, 26$0.98Jun 17, 26$0.94Jun 22, 26$0.96Jun 24, 26$0.92Jun 26, 26$0.95Jul 2, 26$1.00
$0.8652-week range$1.92
Loading valuation history…

Fundamentals

Key fundamentals

$468.3M

Market cap

-9.5%

Revenue growth (YoY)

29.6%

Gross margin

-$124.7M

Free cash flow (USD)

$216.9M

Net debt

5.8%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$12.7MFY 2017$39.9MFY 2018$77.9MFY 2019$226.3MFY 2020$398.8MFY 2021$546.6MFY 2022$475.7MFY 2023$333.3MFY 2024$297.1MFY 2025$269.0M
$12.7M$269M

Free cash flow by year

2016 → 2025

FY 2016$-23.2MFY 2017$-56.6MFY 2018$-259.6MFY 2019$-1.3BFY 2020$-1.5BFY 2021$-639.9MFY 2022$-593.9MFY 2023$-568.0MFY 2024$-285.9MFY 2025$-177.0M
-$23.2M-$177M

Gross margin by year

2021 → 2025

FY 202112.3%FY 2022-39.4%FY 2023-19.1%FY 202427.2%FY 202529.6%
12.3%29.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last reported: Jun 15, 2026 (EPS $-0.17)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $21KLazzarato David Angelo · Director · $20.9KJun 29, 2026Filing
  • Insider sellInsider Sell $3KATKINS M SHAN · Director · $3KJun 29, 2026Filing
  • Insider sellInsider Sell $14KYanofsky Theresa · Director · $13.9KJun 29, 2026Filing
  • Insider sellInsider Sell $3KBAYERN JOSEPH · Director · $3KJun 29, 2026Filing
  • Insider sellInsider Sell $57KGedeon Christelle · See Remarks · $57.5KJun 22, 2026Filing
  • Insider sellInsider Sell $9KStewart Thomas Carlton · See Remarks · $9KJun 22, 2026Filing
  • Insider sellInsider Sell $132KMongeau Luc · Director, Chief Executive Officer · $131.7KJun 22, 2026Filing
  • Annual report10-K FiledJun 15, 2026Filing
  • 8-K eventEarnings ReleaseJun 15, 2026Filing
  • 8-K eventAdvance Notice By-LawMay 27, 2026Filing

Questions

Frequently asked questions

What is Canopy Growth Corporation's market cap?

Canopy Growth Corporation (CGC) has a market capitalization of $468.3M.

What is CGC's P/E ratio?

A meaningful P/E ratio is not available for CGC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CGC's price-to-book (P/B) ratio?

CGC trades at 0.67 times book value per share.

When did Canopy Growth Corporation last report earnings?

CGC last reported earnings on June 15, 2026; the next date is not yet scheduled.

Are insiders buying CGC stock?

SEC Form 4 filings show no open-market insider buys at Canopy Growth Corporation in the last 90 days (7 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

KMDA

Kamada Ltd.

$451.4M

EOLS

Evolus, Inc.

$434.3M

AQST

Aquestive Therapeutics, Inc.

$404.7M

SNDL

SNDL Inc.

$383.8M

IRWD

Ironwood Pharmaceuticals, Inc.

$582M

SIGA

SIGA Technologies, Inc.

$340.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.